Osmotically driven active agent delivery device providing an...

Details Osmotically driven active agent delivery device providing an... Osmotically driven active agent delivery device providing an...

2007-07-10

2007-07-10

Kennedy, Sharon E. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C604S892100

Reexamination Certificate

active

10953895

ABSTRACT:
In one aspect, the present invention is directed to an osmotic pump that automatically provides an ascending release rate of active agent as the osmotic pump functions in an environment of operation and may be designed for implantation within a desired animal or human subject. An osmotic pump according to the present invention includes a reservoir, a rate controlling membrane, an expandable osmotic composition, an active agent formulation and an exit orifice. Once administered to an environment of operation, water passes through the rate controlling membrane and into the osmotic composition, which causes the osmotic composition to expand and expel the active agent formulation through the exit orifice at a rate that is directly proportional to the rate at which water passes through the rate controlling membrane. An osmotic pump according to the present invention permits the flow of water through the rate controlling membrane to increase automatically without the need for manipulation of the osmotic pump after administration. As the flow of water through the rate controlling membrane increases, the rate at which active agent is delivered from the osmotic pump will also increase proportionally.

REFERENCES:
patent: 3625214 (1971-12-01), Higuchi
patent: 4874388 (1989-10-01), Wong et al.
patent: 4976966 (1990-12-01), Theeuwes et al.
patent: 5234693 (1993-08-01), Magruder et al.
patent: 5279608 (1994-01-01), Cherif Cheikh
patent: 5336057 (1994-08-01), Fukuda et al.
patent: 5728396 (1998-03-01), Peery et al.
patent: 5836935 (1998-11-01), Ashton et al.
patent: 5976109 (1999-11-01), Heruth
patent: 5985305 (1999-11-01), Peery et al.
patent: 5997527 (1999-12-01), Gumucio et al.
patent: 5997902 (1999-12-01), Maruyama et al.
patent: 6113938 (2000-09-01), Chen et al.
patent: 6132420 (2000-10-01), Dionne et al.
patent: 6217906 (2001-04-01), Gumucio et al.
patent: 6245357 (2001-06-01), Edgren et al.
patent: 6261584 (2001-07-01), Peery et al.
patent: 6270787 (2001-08-01), Ayer
patent: 6283949 (2001-09-01), Roorda
patent: 6287295 (2001-09-01), Chen et al.
patent: 6375978 (2002-04-01), Kleiner et al.
patent: 6436091 (2002-08-01), Harper et al.
patent: 6464688 (2002-10-01), Harper et al.
patent: 6471688 (2002-10-01), Harper et al.
patent: 2001/0021822 (2001-09-01), Ayer
patent: 2001/0022974 (2001-09-01), Ayer
patent: 2003/0032947 (2003-02-01), Harper et al.
Darney, Philip D., “Subdermal progestin implant contraception,” Current Opinion in Obstetrics and Gynecology 1991, 3:470-476.
“Implantable infusion pumps: Technology poised for takeoff,” BBI Newsletter, vol. 17, No. 12, pp. 209-211, Dec. 1994.
International Search Report dated Apr. 2005 (5 pages).

Affiliated with

Also associated with

Rating

Osmotically driven active agent delivery device providing an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Osmotically driven active agent delivery device providing an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osmotically driven active agent delivery device providing an... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3761511